News

Dr. Reddy's API team at CPHI Milan 2024

We are thrilled to share the incredible success of Dr. Reddy's API team at CPHI Milan 2024, held from October 8th to 10th at Fiera Milano, Italy. This prestigious event brought together over 62,000 attendees and 2,400 exhibitors from 168+ countries, making it a global hub for pharmaceutical innovation and collaboration1.

CPHI Milan provided an excellent platform for networking. Our experts engaged with industry leaders, fostering new partnerships and strengthening existing relationships. The event was a testament to our collaborative spirit and dedication to advancing global health. Sustainability remains at the core of our operations. Our participation at CPHI Milan emphasized our commitment to sustainable practices, aligning with our goal to reach over 1.5 billion patients globally by 20301.

We extend our heartfelt thanks to everyone who visited our booth and engaged with our team. Your support and collaboration are vital as we continue to innovate and deliver high-quality pharmaceutical solutions worldwide.

Dr. Reddys API team at CPHI Milan 2024

Email us: api@drreddys.com
+91 40 49002253

Contact Us

Please fill in the following form and we'll get back to you shortly.

* I agree and accept the Privacy Policy and Terms of Use of this website.

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.